{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 23
    }
  },
  "results": [
    {
      "update_type": "Revised",
      "initial_posting_date": "12/15/2021",
      "package_ndc": "0009-3475-01",
      "generic_name": "Methylprednisolone Acetate Injection",
      "contact_info": "844-646-4398",
      "availability": "Limited Availability",
      "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: December 2026",
      "openfda": {
        "application_number": [
          "NDA011757"
        ],
        "brand_name": [
          "DEPO-MEDROL"
        ],
        "generic_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "manufacturer_name": [
          "Pharmacia & Upjohn Company LLC"
        ],
        "product_ndc": [
          "0009-3475",
          "0009-3073"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRA-ARTICULAR",
          "INTRALESIONAL",
          "INTRAMUSCULAR",
          "SOFT TISSUE"
        ],
        "substance_name": [
          "METHYLPREDNISOLONE ACETATE"
        ],
        "rxcui": [
          "1743779",
          "1743781",
          "1743855",
          "1743856"
        ],
        "spl_id": [
          "742fcec7-8db3-4cc6-b276-42587a993810"
        ],
        "spl_set_id": [
          "9a7b3837-e038-48bf-97e9-78ad463760dc"
        ],
        "package_ndc": [
          "0009-3073-01",
          "0009-3073-03",
          "0009-3475-01",
          "0009-3475-03"
        ],
        "unii": [
          "43502P7F0P"
        ]
      },
      "update_date": "10/21/2026",
      "therapeutic_category": [
        "Rheumatology"
      ],
      "dosage_form": "Injection",
      "presentation": "Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)",
      "company_name": "Pfizer Inc.",
      "shortage_reason": "Demand increase for the drug",
      "status": "Current"
    }
  ]
}